VA <3/60 | | | |
Bilateral blindness | 16 (1.8%) | 13 (1.5%) | 29 (1.6%) |
Unilateral blindness | 75 (8.3%) | 53 (6.0%) | 128 (7.2%) |
Blind eyes | 107 (11.8 %) | 79 (8.9%) | 186 (10.4%) |
VA <6/60–⩾3/60 | | | |
Bilateral severe visual impairment | 18 (2.0%) | 22 (2.5%) | 40 (2.2%) |
Unilateral severe visual impairment | 17 (1.9%) | 20 (2.3%) | 37 (2.1%) |
Severely visually impaired eyes | 53 (5.9%) | 64 (7.2%) | 117 (6.5%) |
VA <6/18–⩾6/60 | | | |
Bilateral visual impairment | 44 (4.9%) | 71 (8.0%) | 115 (6.4%) |
Unilateral visual impairment | 33 (3.6%) | 35 (3.9%) | 68 (3.8%) |
Visually impaired eyes | 121 (13.4%) | 177 (20.0%) | 298 (16.7%) |
Aphakia/pseudophakia | | | |
Bilateral aphakia/pseudophakia | 4 (0.4%) | 2 (0.2%) | 6 (0.3%) |
Unilateral aphakia/pseudophakia | 11 (1.2%) | 5 (0.6%) | 16 (0.9%) |
Aphakic/pseudophakic eyes | 19 (2.1%) | 9 (1.0%) | 28 (1.6%) |